OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crosstalk of toll-like receptors signaling and Nrf2 pathway for regulation of inflammation
S. Venkata Mohan, Damodar Gupta
Biomedicine & Pharmacotherapy (2018) Vol. 108, pp. 1866-1878
Open Access | Times Cited: 162

Showing 1-25 of 162 citing articles:

A Review of the Anti-Inflammatory Effects of Rosmarinic Acid on Inflammatory Diseases
Chunxu Luo, Lin Zou, Huijun Sun, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 245

Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis
Gregory Livshits, Alexander Kalinkovich
Ageing Research Reviews (2019) Vol. 56, pp. 100980-100980
Closed Access | Times Cited: 174

Superoxide Dismutase Administration: A Review of Proposed Human Uses
Arianna Carolina Rosa, Daniele Corsi, Niccolò Cavi, et al.
Molecules (2021) Vol. 26, Iss. 7, pp. 1844-1844
Open Access | Times Cited: 154

Exosomes from adipose-derived stem cells alleviate the inflammation and oxidative stress via regulating Nrf2/HO-1 axis in macrophages
Kuo Shen, Yanhui Jia, Xujie Wang, et al.
Free Radical Biology and Medicine (2021) Vol. 165, pp. 54-66
Closed Access | Times Cited: 148

Redox signaling at the crossroads of human health and disease
Jing Zuo, Zhe Zhang, Maochao Luo, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 79

Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics
Mei Jin, Jian Fang, Jiaojiao Wang, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 12, pp. 2358-2375
Closed Access | Times Cited: 44

Nrf2: a dark horse in doxorubicin-induced cardiotoxicity
Xiaopeng Zhao, Zheng Tian, Mingli Sun, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 42

Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19
Gregorio Martı́nez-Sánchez, Adriana Schwartz, Vincenzo Di Donna
Antioxidants (2020) Vol. 9, Iss. 5, pp. 389-389
Open Access | Times Cited: 131

Itaconate prevents abdominal aortic aneurysm formation through inhibiting inflammation via activation of Nrf2
Haoyu Song, Tong Xu, Xiaofei Feng, et al.
EBioMedicine (2020) Vol. 57, pp. 102832-102832
Open Access | Times Cited: 97

Modulation of Oxidative Stress by Ozone Therapy in the Prevention and Treatment of Chemotherapy-Induced Toxicity: Review and Prospects
Bernardino Clavo, Francisco Rodríguez‐Esparragón, Delvys Rodríguez‐Abreu, et al.
Antioxidants (2019) Vol. 8, Iss. 12, pp. 588-588
Open Access | Times Cited: 88

Protective Role of Nrf2 in Renal Disease
Melania Guerrero‐Hue, Sandra Rayego‐Mateos, Cristina Vázquez‐Carballo, et al.
Antioxidants (2020) Vol. 10, Iss. 1, pp. 39-39
Open Access | Times Cited: 86

Attenuation of Nrf2/Keap1/ARE in Alzheimer’s Disease by Plant Secondary Metabolites: A Mechanistic Review
Sajad Fakhri, Mirko Pesce, Antonia Patruno, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 4926-4926
Open Access | Times Cited: 74

NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases
Ángel Cores, Marta Piquero, Mercedes Villacampa, et al.
Biomolecules (2020) Vol. 10, Iss. 6, pp. 904-904
Open Access | Times Cited: 73

Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies
Jean Bousquet, Jean‐Paul Cristol, Heather J. Zar, et al.
Clinical and Translational Allergy (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 71

Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2/NQO-1 pathway
Yaxing Kang, Yiran Song, Yuxin Luo, et al.
Free Radical Biology and Medicine (2022) Vol. 192, pp. 25-36
Closed Access | Times Cited: 69

Nrf2: An all-rounder in depression
Chengchao Zuo, Huấn Cao, Yu Song, et al.
Redox Biology (2022) Vol. 58, pp. 102522-102522
Open Access | Times Cited: 69

A study of the potential effect of yellow mealworm (Tenebrio molitor) substitution for fish meal on growth, immune and antioxidant capacity in juvenile largemouth bass (Micropterus salmoides)
Jiaze Gu, Hualiang Liang, Xianping Ge, et al.
Fish & Shellfish Immunology (2021) Vol. 120, pp. 214-221
Closed Access | Times Cited: 63

Pistachio hull polysaccharide protects Nile tilapia against LPS-induced excessive inflammatory responses and oxidative stress, possibly via TLR2 and Nrf2 signaling pathways
Ghasem Mohammadi, Ali Karimi, M. Hafezieh, et al.
Fish & Shellfish Immunology (2021) Vol. 121, pp. 276-284
Closed Access | Times Cited: 57

Regulation of innate immunity by Nrf2
Demi van der Horst, ME Carter-Timofte, J van Grevenynghe, et al.
Current Opinion in Immunology (2022) Vol. 78, pp. 102247-102247
Open Access | Times Cited: 48

Modulation of p38 MAPK and Nrf2/HO-1/NLRP3 inflammasome signaling and pyroptosis outline the anti-neuroinflammatory and remyelinating characters of Clemastine in EAE rat model
Tarek K. Motawi, Shohda A. El‐Maraghy, Ahmed S. Kamel, et al.
Biochemical Pharmacology (2023) Vol. 209, pp. 115435-115435
Closed Access | Times Cited: 25

The Nrf2 Pathway in Depressive Disorders: A Systematic Review of Animal and Human Studies
Gabriele Sani, Stella Margoni, Andrea Brugnami, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 817-817
Open Access | Times Cited: 24

Nrf2-mediated ferroptosis inhibition: a novel approach for managing inflammatory diseases
Hang Han, Guojiang Zhang, Xiao Zhang, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2961-2986
Closed Access | Times Cited: 14

SIRT3: A potential therapeutic target for liver fibrosis
Yan Ning, Xinyue Dou, Zhichao Wang, et al.
Pharmacology & Therapeutics (2024) Vol. 257, pp. 108639-108639
Closed Access | Times Cited: 9

Page 1 - Next Page

Scroll to top